🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
618
$6185.HK
🔒 Asia-PacificCANSINOBIO
AVG HISTORICAL GAP
+1.23%
MAX GAP RECORD
+3.36%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $6185.HK
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$6185.HK
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 27, 2026 Earnings Release 2026-10-27 (AFTER CLOSE (16:00)) |
+1.60%
|
| Aug 27, 2026 Earnings Release 2026-08-27 (AFTER CLOSE) |
-0.57%
|
| Feb 26, 2026 Earnings Release 2026-02-26 (AFTER CLOSE) |
+2.11%
|
| Oct 27, 2025 Earnings Release 2025-10-27 (AFTER CLOSE) |
+3.36%
|
| Mar 25, 2025 Earnings Release 2025-03-25 (AFTER CLOSE) |
+2.11%
|
| Aug 29, 2024 Earnings Release 2024-08-29 (AFTER CLOSE) |
+2.89%
|
| Apr 29, 2024 Earnings Release 2024-04-29 (AFTER CLOSE) |
-1.28%
|
| Mar 27, 2023 Earnings Release 2023-03-27 (AFTER CLOSE) |
-0.42%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
1.8%
Bullish Gaps (5)
Bearish Gaps (1)
Neutral / Flat (2)
📖 Intelligence Summary
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗